Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MACS Study - Microparticles and Coagulation in Sickle Cell Disease: An Observational Study to Measure the Levels of Circulating Microvesicles and Coagulation Activation Parameters in Patients With Sickle Cell Disease in the in- and Out-patient Setting.

NCT01242878 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01242878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01242878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MACS Study - Microparticles and Coagulation in Sickle Cell Disease: An Observational Study to Measure the Levels of Circulating Microvesicles and Coagulation Activation Parameters in Patients With Sickle Cell Disease in the in- and Out-patient Setting.
Lead sponsor
University College, London
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2010
Completion date
Not reported
Enrollment
360 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease